Form 8-K - Current report:
SEC Accession No. 0001213900-25-067772
Filing Date
2025-07-25
Accepted
2025-07-25 16:30:27
Documents
14
Period of Report
2025-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0250233-8k_ispecimen.htm   iXBRL 8-K 30384
2 PRESS RELEASE DATED JULY 24, 2025, ANNOUNCING THE PRICING OF THE OFFERING ea025023301ex99-1_ispecimen.htm EX-99.1 8282
3 PRESS RELEASE DATED JULY 25, 2025, ANNOUNCING THE CLOSING OF THE OFFERING ea025023301ex99-2_ispecimen.htm EX-99.2 8210
  Complete submission text file 0001213900-25-067772.txt   222810

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ispc-20250723.xsd EX-101.SCH 3017
5 XBRL LABEL FILE ispc-20250723_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE ispc-20250723_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0250233-8k_ispecimen_htm.xml XML 3782
Mailing Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101
Business Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40501 | Film No.: 251152038
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)